Back to results
US 12,577,274 B2Granted
Manufacture of glucagon peptides
AssigneeBachem Holding AG
InventorsRalf Eisenhuth, Guenther Loidl, Daniel Samson, Ralph O. Schoenleber
Life of this patent
Estimating the term…
Abstract
The present invention refers to a method of purifying a glucagon peptide, the method comprising a two dimensional reversed phase high performance liquid chromatography protocol, wherein the first step is carried out at using a mobile phase comprising a triethylammonium phosphate (TEAP) buffer and acetonitrile, and the second step is carried out at using a mobile phase comprising aqueous acetic acid and acetonitrile.
Claims21
A method for the preparation of purified glucagon peptide, comprising:
- a) providing a liquid composition C comprising a chemically synthesized glucagon peptide and at least one peptidic impurity selected from a glucagon derivative, a glucagon truncation variant, a derivative of a glucagon truncation variant, a glucagon deletion variant, a derivative of a glucagon deletion variant, and a combination thereof;
- b) subjecting the composition C to a first reversed phase high performance liquid chromatography (RP-HPLC) purification, wherein a hydrocarbon bonded silica is used as a stationary phase, an aqueous mobile phase of pH 6.5 to 7.5 comprising triethylammonium phosphate and acetonitrile is used, and elution is effected by gradually increasing the acetonitrile concentration within the mobile phase while collecting fractions containing the glucagon peptide;
- and
- c) subjecting the pooled glucagon peptide-containing fractions obtained in step b) to a second reversed phase HPLC purification, wherein a hydrocarbon bonded silica is used as a stationary phase, a mobile phase comprising acetic acid and acetonitrile is used, wherein the concentration of acetic acid in the mobile phase of step c) is between 0.5 and 5% v/v, and elution is effected by gradually increasing the acetonitrile concentration within the mobile phase while collecting and pooling fractions containing the purified glucagon peptide,
- wherein the same stationary phase is used in steps b) and c).
2 more elements
Dependencies are inferred from the claim text.